Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001036050-98-000478
Filing Date
1998-03-27
Accepted
1998-03-27 00:00:00
Documents
7
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 173345
2 CONSULTING AGREEMENT EX-10.26 7527
3 STATEMENT OF COMPUTATION OF PRO FORMA LOSS PER SHARE EX-11 1848
4 CONSENT OF KPMG PEAT MARWICK LLP EX-23 862
5 FINANCIAL DATA SCHEDULE EX-27.1 2964
6 FINANCIAL DATA SCHEDULE EX-27.2 2079
7 EXHIBIT 99 EX-99 43870
  Complete submission text file 0001036050-98-000478.txt   234558
Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 76 GREAT VALLEY PARKWAY PO BOX 5000 MALVERN PA 19355 6106510200
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-21699 | Film No.: 98576540
SIC: 2834 Pharmaceutical Preparations